Esther Rajavelu
Stock Analyst at UBS
(0.74)
# 3,726
Out of 4,732 analysts
27
Total ratings
46.67%
Success rate
-23.19%
Average return
Main Sectors:
Top Industries:
Stocks Rated by Esther Rajavelu
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| APLT Applied Therapeutics | Downgrades: Neutral | $13 → $2 | $0.65 | +206.28% | 3 | Dec 2, 2024 | |
| DNLI Denali Therapeutics | Maintains: Buy | $70 → $32 | $21.93 | +45.92% | 2 | Apr 9, 2024 | |
| ALNY Alnylam Pharmaceuticals | Upgrades: Buy | $141 → $215 | $246.27 | -12.70% | 5 | Oct 4, 2021 | |
| RARE Ultragenyx Pharmaceutical | Initiates: Sell | $73 | $40.00 | +82.50% | 1 | Aug 19, 2021 | |
| BHVN Biohaven | Downgrades: Neutral | $108 → $109 | $37.59 | +189.97% | 6 | Aug 10, 2021 | |
| STOK Stoke Therapeutics | Initiates: Neutral | $35 | $9.36 | +273.93% | 1 | May 18, 2021 | |
| IONS Ionis Pharmaceuticals | Upgrades: Neutral | $33 → $38 | $31.43 | +19.31% | 3 | May 7, 2021 | |
| JAZZ Jazz Pharmaceuticals | Maintains: Buy | $174 → $228 | $121.18 | +88.15% | 1 | Mar 1, 2021 | |
| EYEN Eyenovia | Downgrades: Perform | n/a | $0.06 | - | 2 | Feb 3, 2020 | |
| ARWR Arrowhead Pharmaceuticals | Initiates: Perform | n/a | $19.56 | - | 1 | Dec 13, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Hold | $13 | $18.58 | -30.03% | 1 | Nov 20, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $10 | $1.06 | +843.40% | 1 | Jul 21, 2017 |
Applied Therapeutics
Dec 2, 2024
Downgrades: Neutral
Price Target: $13 → $2
Current: $0.65
Upside: +206.28%
Denali Therapeutics
Apr 9, 2024
Maintains: Buy
Price Target: $70 → $32
Current: $21.93
Upside: +45.92%
Alnylam Pharmaceuticals
Oct 4, 2021
Upgrades: Buy
Price Target: $141 → $215
Current: $246.27
Upside: -12.70%
Ultragenyx Pharmaceutical
Aug 19, 2021
Initiates: Sell
Price Target: $73
Current: $40.00
Upside: +82.50%
Biohaven
Aug 10, 2021
Downgrades: Neutral
Price Target: $108 → $109
Current: $37.59
Upside: +189.97%
Stoke Therapeutics
May 18, 2021
Initiates: Neutral
Price Target: $35
Current: $9.36
Upside: +273.93%
Ionis Pharmaceuticals
May 7, 2021
Upgrades: Neutral
Price Target: $33 → $38
Current: $31.43
Upside: +19.31%
Jazz Pharmaceuticals
Mar 1, 2021
Maintains: Buy
Price Target: $174 → $228
Current: $121.18
Upside: +88.15%
Eyenovia
Feb 3, 2020
Downgrades: Perform
Price Target: n/a
Current: $0.06
Upside: -
Arrowhead Pharmaceuticals
Dec 13, 2019
Initiates: Perform
Price Target: n/a
Current: $19.56
Upside: -
Nov 20, 2017
Initiates: Hold
Price Target: $13
Current: $18.58
Upside: -30.03%
Jul 21, 2017
Initiates: Buy
Price Target: $10
Current: $1.06
Upside: +843.40%